Live Breaking News & Updates on Leukemia Registry

Stay updated with breaking news from Leukemia registry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Aldoss on the Mechanism of Action of Ponatinib in Ph+ ALL

Ibrahim Aldoss, MD, discusses the use of ponatinib as evaluated in the PhALLCON trial for patients with Ph+ ALL. ....

United States , Ibrahim Aldoss , Hematology Tissue Bank , Division Of Leukemia , Leukemia Research , Department Of Hematology , Gehr Family Center , Hematopoietic Cell Transplantation , Leukemia Registry , Hematologic Oncology , Onclive Tv , City Of Hope ,